Loss of asparagine-linked glycosylation sites in variable region 5 of human immunodeficiency virus type 1 envelope is associated with resistance to CD4 antibody ibalizumab (Q33810849)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Loss of asparagine-linked glycosylation sites in variable region 5 of human immunodeficiency virus type 1 envelope is associated with resistance to CD4 antibody ibalizumab |
scientific article |
Statements
1 reference
Loss of asparagine-linked glycosylation sites in variable region 5 of human immunodeficiency virus type 1 envelope is associated with resistance to CD4 antibody ibalizumab (English)
1 reference
Christos J Petropoulos
1 reference
Jonathan Toma
1 reference
Steven P Weinheimer
1 reference
Eric Stawiski
1 reference
Jeannette M Whitcomb
1 reference
Stanley T Lewis
1 reference
Wei Huang
1 reference
2 February 2011
1 reference
1 reference
85
1 reference
3872-3880
1 reference
Identifiers
1 reference
1 reference
1 reference